Your browser doesn't support javascript.
loading
Hyperthermia and multiorgan failure after abuse of "bath salts" containing 3,4-methylenedioxypyrovalerone.
Borek, Heather A; Holstege, Christopher P.
Afiliação
  • Borek HA; Division of Medical Toxicology, Department of Emergency Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA.
Ann Emerg Med ; 60(1): 103-5, 2012 Jul.
Article em En | MEDLINE | ID: mdl-22387085
ABSTRACT
"Bath salts" are being increasingly used as drugs of abuse. These products have been found to contain a variety of compounds, including 3,4-methylenedioxypyrovalerone (MDPV). We present a case of a 25-year-old man who injected bath salts and acutely developed severe agitation, hyperthermia, and tachycardia. Despite aggressive early medical management, including dialysis, he progressed to multiorgan system failure, although he ultimately recovered after a prolonged hospital course. The only chemical substance detected on comprehensive toxicologic testing was MDPV, a synthetic cathinone analogue. According to our case, MDPV abuse may result in adverse multisystem organ effects, including rhabdomyolysis, cardiac injury, hepatic injury, and renal failure. It is unknown whether these end-organ effects were due to direct cellular toxicity induced by MDPV or a result of the patient's marked agitation and hyperthermia. Acute management should focus on the rapid identification of organ injury and appropriate supportive care.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirrolidinas / Drogas Desenhadas / Benzodioxóis / Febre / Insuficiência de Múltiplos Órgãos Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirrolidinas / Drogas Desenhadas / Benzodioxóis / Febre / Insuficiência de Múltiplos Órgãos Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2012 Tipo de documento: Article